US20070231370A1 - Guanidino Acetic Acid Used as an Animal Food Additive - Google Patents

Guanidino Acetic Acid Used as an Animal Food Additive Download PDF

Info

Publication number
US20070231370A1
US20070231370A1 US11/596,771 US59677105A US2007231370A1 US 20070231370 A1 US20070231370 A1 US 20070231370A1 US 59677105 A US59677105 A US 59677105A US 2007231370 A1 US2007231370 A1 US 2007231370A1
Authority
US
United States
Prior art keywords
composition
acid
salt
creatine
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/596,771
Other languages
English (en)
Inventor
Thomas Gastner
Hans-Peter Krimmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alzchem Trostberg GmbH
Original Assignee
Alzchem Trostberg GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34969080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20070231370(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alzchem Trostberg GmbH filed Critical Alzchem Trostberg GmbH
Assigned to DEGUSSA AG reassignment DEGUSSA AG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GASTNER, THOMAS, KRIMMER, HANS-PETER
Publication of US20070231370A1 publication Critical patent/US20070231370A1/en
Assigned to ALZCHEM TROSTBERG GMBH reassignment ALZCHEM TROSTBERG GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: DEGUSSA AG
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K61/00—Culture of aquatic animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/105—Aliphatic or alicyclic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/153—Nucleic acids; Hydrolysis products or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K61/00—Culture of aquatic animals
    • A01K61/10—Culture of aquatic animals of fish
    • A01K61/13—Prevention or treatment of fish diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish
    • Y02A40/818—Alternative feeds for fish, e.g. in aquacultures

Definitions

  • the present invention relates to the use of guanidinoacetic acid or of salts of guanidinoacetic acid as feed additive.
  • Guanidinoacetic acid is an endogenous substance in animals and humans which takes a central role in the biosynthesis of creatine. Creatine can be both taken by the diet, and also formed endogenously. Its biosynthesis proceeds from glycine and L-arginine. In mammals, primarily in the kidneys, but also in the liver and pancreas, the guanidino group of the L-arginine is cleaved by the enzyme aminotransferase and an N—C—N group is transferred to the glycine. The L-arginine is converted in this case to L-ornithine.
  • the guanidinoacetic acid thus formed is converted in the next step to creatine using the enzyme transmethylase, in vertebrates this takes place exclusively in the liver.
  • the S-adenosylmethionine acts as methyl group donor. Creatine then diffuses into the blood circulation and is thus transported to the target organs. Transport through the cell membrane into the cells takes place in this case via a specific creatine transporter.
  • the abovementioned creatine takes an important role in the energy metabolism of the cell, it being, as high-energy phosphocreatine, in addition to adenosin triphosphate (ATP), an important energy reserve of muscle.
  • ATP adenosin triphosphate
  • ATP can transfer a phosphate group to creatine, phosphate creatine being formed which is then in direct equilibrium with ATP.
  • the phosphocreatine is available therefor in the first seconds of maximum muscle load. This phosphocreatine can transfer a phosphate group to adenosin diphosphate by the enzyme creatine kinase in a very rapid reaction and thus reform ATP. This is also termed the Lohmann reaction.
  • Creatine has long been known as a suitable food and feed supplement.
  • the creatine reserves which natural are present in the body are rapidly exhausted.
  • targeted creatine administration has had beneficial effects on stamina and performance, with unwanted enrichment processes in the body or disadvantageous degradation products being unknown.
  • the reason for this is that creatine is excreted by the body as creatinine in the case of excess supply.
  • creatine supplementation leads to increase in body mass. This is at the beginning ascribed to increased uptake of water into the muscle. In the long term, creatine indirectly leads to an increase in muscle mass (Int J Sports Med 21 (2000), 139-145) via increased protein synthesis or a decreased protein catabolism in the myofibrils. As a result increased fat-free body mass is thus obtained.
  • Creatine also exhibits the effects demonstrated as beneficial to humans in animals, for which reason its use has likewise been sufficiently previously described in diverse feeds.
  • the international patent application WO 00/67 590 has previously described the use of creatine or creatine salts as feed additive for breeding and growing livestock, as replacement for meat meal, fish meal and/or antimicrobial performance enhancers, growth hormones as well as anabolic agents.
  • GB 2 300 103 teaches the use of creatine in the form of a dog biscuit, for which creatine monohydrate is offered together with meat in an extruded mix. Since creatine monohydrate, owing to its poor solubility, is only insufficiently bioavailable, its joint use together with other physiologically active compounds, preferably in salt form, is recommended.
  • German Laid-Open application DE 198 36 450 A1 has, as subject matter, the use of stable pyruvic acid salts, and in particular creatine pyruvate, in formulations which are suitable for animal nutrition.
  • DE 100 03 835 A1 has, as subject matter, formulations for dehydration conditions as generally occur in older persons, in particular those having restricted mobility.
  • creatine acts as a transport medium for water in order in this manner to supply moisture to the tissues most severely affected by dehydration symptoms.
  • creatine In addition to its undisputed beneficial physiological properties, creatine, however, has the disadvantage that, as creatine monohydrate, it does not have pronounced stability in the corresponding aqueous solutions in that it converts itself over a relatively long period into creatinine. This is a problem especially in acidic solutions and is thus also of importance for oral intake and bioavailability of creatine.
  • the pH of the stomach of 1 to 2 can, depending on the residence time, lead to significant breakdown of the creatine to form creatinine. For instance, in humans it has been found that after oral application of creatine, only about 15 to 30% can be resorbed by the musculature (Greenhaff, P. L.: Factors Modifying Creatine Accumulation in Human Skeletal Muscle. In: Creatine, From Basic Science to Clinical Application. Medical Science Symposia Series Volume 14, 2000, 75-82).
  • the disadvantages of the prior art with respect to creatine have produced the object of the present invention to find compounds which can be used as feeds or feed additive for breeding and growing livestock and have a beneficial effect on improving feed uptake, increasing the growth performance, raising the muscle flesh gain, meat quality and/or the reproduction performance.
  • the compounds should have as low an instability as possible, in particular in aqueous solution, and preferably not be converted into creatine until after application or physiological uptake.
  • the feeds or feed additives used should not themselves develop any physiologically disadvantageous effects and be readily detectable. From commercial aspects, of primary importance for the substances to be used according to the invention was also the fact that they should be able to be produced in an economically expedient manner.
  • This object has been achieved by the use of guanidinoacetic acid and/or salts of guanidinoacetic acid as feed additive for breeding and growing livestock in predominantly vegetarian diets to improve feed uptake, to increase growth performance, muscle meat gain, meat quality and/or reproduction performance.
  • predominantly vegetarian diet describes a diet which preferably contains no animal components in agreement with the legal directives in the European Union. The only exception in this case is a possible addition of fish meal.
  • the “predominantly vegetarian diet” according to this invention is also to be taken to mean a partial replacement of fish meal or meat meal by guanidinoacetic acid.
  • the claimed compounds in fact have the properties desired according to the object, since they can be produced in a simple and economic manner, for example by methods such as the reaction of glycine and cyanamide in aqueous solutions (Production of guanidino fatty acids (Vassel, Bruno; Janssens, Walter D.) (1952), U.S. Pat. No. 2,620,354; Method of preparation of guanidino fatty acids (Vassel, Bruno; Garst, Roger) (1953), 5 pp U.S. Pat. No. 2,654,779).
  • guanidinoacetic acid and salts thereof in addition exhibit a significantly higher stability in acidic aqueous solution and they are not converted to creatine until under physiological conditions.
  • the guanidinoacetic acid and salts thereof used according to the invention in contrast to creatine, are in fact not converted to creatine until after resorption, principally in the liver.
  • the majority of the compounds administered or fed, guanidinoacetic acid and/or salts of guanidinoacetic acid are not degraded by instability reactions, for example in the stomach, and excreted before resorption, but are in fact available in the corresponding physiological metabolic reactions.
  • Guanidinoacetic acid and salts thereof can be used according to the invention, but again in contrast to creatine and derivatives thereof, with identical activity at significantly lower dosage.
  • the advantages of the use claimed by the invention could not be predicted in their totality, in particular because guanidinoacetic acids, for example in chicks, had been ascribed adverse activity on feed utilization and weight gain.
  • guanidinoacetic acid and salts thereof as feed additive has proved very effective, for example, for poultry such as, for example, chicks, turkeys, ducks and geese, but also for pigs.
  • the present invention in another embodiment, provides using guanidinoacetic acid and/or suitable salts thereof as supplementation or alternatively as feed additive in aquacultures, preferably as partial or total replacement of fish meal and/or antimicrobial performance enhancers, whereas the proposed use being preferred for salmon types (Salmonides) and shrimp types (Natania).
  • Antimicrobial performance enhancers are substances such as, for example, carbadox, olaquindox, salinomycin, monensin, avilamycin or flavomycin. These are used in particular to prevent the spread of diseases in animals. Further, increased efficiency in animal production shall be achieved. Antimicrobial performance enhancers are also used to avoid transmission of the zoonoses to humans and thus enable the production of high quality and safe animal foods.
  • the present invention also relates to the use of guanidinoacetic acid and/or salts thereof for the production of a therapeutic composition for breeding and growing livestock which can be used to strengthen the immune system and to improve reproduction performance.
  • the described therapeutic composition in a preferred embodiment, is preferably used in poultry and/or pigs.
  • guanidinoacetic acid salts are suitable which are acceptable in terms of nutritional physiology.
  • salts of guanidinoacetic acid have proved expedient which are obtained with hydrochloric acid, hydrobromic acid and phosphoric acid. Mixtures of guanidinoacetic acid with one or more of these salts or else mixtures of the salts with one another can also be used.
  • guanidinoacetic acid and salts thereof can be used in a wide dose range.
  • Daily doses in chicks, per kg of live mass are, for example, in the range between about 10 mg and about 1200 mg, in particular in the range from about 50 mg to about 250 mg.
  • Individual doses are generally in the range from about 10 mg and about 600 mg, preferably in the range from about 25 to about 125 mg.
  • daily doses, per kg of live mass are, for example, in the range from about 10 mg and about 1000 mg, in particular in the range from about 25 mg to about 150 mg.
  • Individual doses are generally in the range from about 10 mg and about 500 mg, preferably in the range from about 10 mg to about 500 mg, preferably in the range from about 10 to 100 mg.
  • feed additive depending on animal species, preferably doses of about 0.01 to about 100 g/kg of feed or therapeutic composition come into consideration, amounts from about 1.0 to about 5.0 g being considered as particularly preferred.
  • feed additives Since the claimed use is preferably performed in the non-veterinary field of use, application forms of feed additives have proved particularly suitable which represent powders, granules, pastilles, capsules, pellets or gel (hydrocolloid) products. It is preferred here, depending on the respective specific application, to use guanidinoacetic acid and salts thereof as feed additive in combination with other physiologically active compounds, in particular carbohydrates, fats, amino acids (e.g. creatine), proteins, vitamins, minerals, trace elements and derivatives thereof and any desired mixtures thereof being particularly suitable. Preference is given to methionine, betaine and choline and also other physiologically active methyl group donors.
  • Betaine and choline in the presence of homocysteine, can be converted to methionine in the body, which especially plays a role in the synthesis of creatine from guanidinoacetic acid.
  • methyl groups are required which are transferred from S-adenosylmethionine with formation of homocysteine. If betaine or choline are insufficiently available, methionine is consumed and a methionine deficit can occur in metabolism.
  • a further aspect of the present invention is thus the use of guanidinoacetic acid and/or salts thereof for production of a composition for breeding and growing livestock for prevention and mitigation of the consequences of heat stress, in particular for reducing mortality as a result of elevated ambient temperatures.
  • the invention provides, in particular, that the therapeutic composition serves in predominantly vegetarian diets as partial and/or total replacement of fish meal, meat meal, anabolic agents (e.g. stilbenes, steroids, thyreostatics and ⁇ -agonists), antimicrobial performance enhancers and/or growth hormones.
  • guanidinoacetic acid and salts thereof can be used as feed additive for wet and dry feeds for dogs and cats, whereas positive effects result on the immune system and the general status of the animals.
  • guanidinoacetic acid and salts thereof are supplied to new applications as feeds and feed additive, respectively, in the nutrition of breeding and growing livestock or as therapeutic composition for breeding and growing livestock, which, in contrast to the creatine compounds previously used, have significant and surprising advantages.
  • the examples hereinafter further illustrate the present invention.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Fodder In General (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
US11/596,771 2004-06-09 2005-06-07 Guanidino Acetic Acid Used as an Animal Food Additive Abandoned US20070231370A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE102004028193 2004-06-09
DE102004028193.9 2004-06-09
DE102004059761.8 2004-12-11
DE102004059761 2004-12-11
PCT/EP2005/006110 WO2005120246A1 (de) 2004-06-09 2005-06-07 Guanidinoessigsäure als futtermittelzusatz

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/006110 A-371-Of-International WO2005120246A1 (de) 2004-06-09 2005-06-07 Guanidinoessigsäure als futtermittelzusatz

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/164,973 Continuation US8501810B2 (en) 2004-06-09 2011-06-21 Guanidino acetic acid used as an animal food additive

Publications (1)

Publication Number Publication Date
US20070231370A1 true US20070231370A1 (en) 2007-10-04

Family

ID=34969080

Family Applications (3)

Application Number Title Priority Date Filing Date
US11/596,771 Abandoned US20070231370A1 (en) 2004-06-09 2005-06-07 Guanidino Acetic Acid Used as an Animal Food Additive
US13/164,973 Active US8501810B2 (en) 2004-06-09 2011-06-21 Guanidino acetic acid used as an animal food additive
US13/738,452 Abandoned US20130296431A1 (en) 2004-06-09 2013-01-10 Guanidino acetic acid used as an animal food additive

Family Applications After (2)

Application Number Title Priority Date Filing Date
US13/164,973 Active US8501810B2 (en) 2004-06-09 2011-06-21 Guanidino acetic acid used as an animal food additive
US13/738,452 Abandoned US20130296431A1 (en) 2004-06-09 2013-01-10 Guanidino acetic acid used as an animal food additive

Country Status (25)

Country Link
US (3) US20070231370A1 (es)
EP (1) EP1758463B1 (es)
JP (1) JP5227021B2 (es)
KR (1) KR101230977B1 (es)
CN (1) CN1964633B (es)
AT (1) ATE381892T1 (es)
AU (1) AU2005251451B2 (es)
BR (1) BRPI0511842B1 (es)
CA (1) CA2569269C (es)
CY (1) CY1107249T1 (es)
DE (1) DE502005002355D1 (es)
DK (1) DK1758463T3 (es)
ES (1) ES2296186T3 (es)
HK (1) HK1096263A1 (es)
HR (1) HRP20080035T3 (es)
MX (1) MXPA06014279A (es)
NO (1) NO335082B1 (es)
NZ (1) NZ551661A (es)
PL (1) PL1758463T3 (es)
PT (1) PT1758463E (es)
RS (1) RS50556B (es)
RU (1) RU2341972C2 (es)
SI (1) SI1758463T1 (es)
WO (1) WO2005120246A1 (es)
ZA (1) ZA200609861B (es)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090098239A1 (en) * 2006-03-01 2009-04-16 Alzchem Trostberg Gmbh Ready-to-Eat Feed for Domestic Pets
US20090297656A1 (en) * 2005-08-02 2009-12-03 Thomas Gastner Liquid Formulation Based On a Guanidinoacetic Acid Component
US20100143703A1 (en) * 2007-07-21 2010-06-10 Stephan Winkler Abrasion-resistant free-flowing glycocyamine-containing mouldings and methods for their production
US8536222B2 (en) 2005-03-04 2013-09-17 Alzchem Ag Addition compounds of guanidinoacetic acid
CN114938830A (zh) * 2022-05-05 2022-08-26 北京中科万联科技有限公司 一种基于氨基酸提升畜禽瘦肉率的饲料添加剂及其制备方法和应用
CN115553403A (zh) * 2022-11-03 2023-01-03 上海海洋大学 凡纳滨对虾肉质改善剂及其制备方法和应用
US11633373B2 (en) 2020-03-04 2023-04-25 Alzchem Trostberg Gmbh Method for reduction of behavioral disorders in pigs

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005009990A1 (de) 2005-03-04 2006-09-07 Degussa Ag Salze, Anlagerungs- und Komplexverbindungen der Guanidinoessigsäure
DE102006050931A1 (de) * 2006-10-28 2008-04-30 Alzchem Trostberg Gmbh Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
KR101423801B1 (ko) 2006-11-28 2014-07-25 도쿄 오카 고교 가부시키가이샤 후막용 화학증폭형 포지티브형 포토레지스트 조성물, 후막용 화학증폭형 드라이 필름 및 후막 레지스트 패턴의 제조 방법
DE102007004781A1 (de) * 2007-01-31 2008-08-07 Alzchem Trostberg Gmbh Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels
DE102007053369A1 (de) * 2007-11-09 2009-07-02 Alzchem Trostberg Gmbh Verwendung einer eine Kreatin-Komponente enthaltende Zusammensetzung zur Verbesserung der männlichen Fruchtbarkeit
CN101912044A (zh) * 2010-08-13 2010-12-15 青岛天通生物科技有限公司 促肌肉生成的组合物及其制备方法
CN103549198B (zh) * 2013-11-05 2015-09-09 安徽科技学院 一种无抗生素肉鸡复合饲料添加剂
CN103549134B (zh) * 2013-11-05 2014-11-05 安徽科技学院 一种不含抗生素的肉鸡复合饲料添加剂
EP2904911A1 (de) * 2014-02-11 2015-08-12 Evonik Degussa GmbH Verwendung von Guanidinoessigsäure und/oder Kreatin zur Erhöhung der Schlupfrate
CN104082205A (zh) * 2014-06-17 2014-10-08 怀远县孔津湖农业开发有限公司 一种泥鳅人工养殖池塘的防逃、防敌害设施
CN104082202A (zh) * 2014-06-17 2014-10-08 怀远县孔津湖农业开发有限公司 一种泥鳅产卵孵化用环道
CN104605161B (zh) * 2015-01-23 2018-02-27 长沙兴嘉生物工程股份有限公司 胍基乙酸配合物的制备方法及其应用
CN105076769A (zh) * 2015-08-04 2015-11-25 固安君德同创生物工程有限公司 一种猪饲料添加剂及其制备和使用方法
CN105076719A (zh) * 2015-08-04 2015-11-25 北京君德同创农牧科技股份有限公司 一种肉鸡用预混料及其制备和使用方法
CN106036197A (zh) * 2016-05-25 2016-10-26 中国水产科学研究院黑龙江水产研究所 一种无鱼粉鲟鱼饲料的添加剂及其制备方法和使用方法
CN107183341A (zh) * 2017-06-13 2017-09-22 肖鹏宏 无草育肥驴饲料及其制备方法
BR112020019467A2 (pt) * 2018-03-27 2020-12-29 Evonik Operations Gmbh Uso de ácido guanidinoacético e/ou creatina em aquicultura
CN108308402A (zh) * 2018-04-02 2018-07-24 四川铁骑力士实业有限公司 一种用于60kg以上乌金猪的配合饲料
CN109258935A (zh) * 2018-10-10 2019-01-25 江苏奥迈生物科技有限公司 饲料用促生长抗氧化复合添加剂及其制备方法和应用
EP3677329B1 (en) 2019-01-02 2021-07-21 Evonik Operations GmbH Process for preparing guanidino acetic acid
BR112021014403A2 (pt) 2019-01-24 2021-09-28 Sil'innov Srcl Composição de ração e água potável para aves que compreende um complexo de silício estável e biodisponível
EP3989733A1 (en) 2019-06-28 2022-05-04 RXW Group NV Poultry feed and drinking water composition comprising monomethylsilanetriol
IL275660B2 (en) 2019-07-12 2023-06-01 Alzchem Trostberg Gmbh Modification of a stimulating crystal and method for its production
DE102019118898A1 (de) 2019-07-12 2021-01-14 Alzchem Trostberg Gmbh Konzentrat zur Herstellung einer Tränklösung
DE102019120249A1 (de) * 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verwendung einer Zusammensetzung zur Reduzierung der Feuchtigkeit und des Stickstoffgehalts in Faeces von Geflügel
DE102019120246A1 (de) 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verfahren zur Fütterung von Geflügel
DE102019120244A1 (de) * 2019-07-26 2021-01-28 Alzchem Trostberg Gmbh Verwendung einer Zusammensetzung zur Verminderung des Federverlustes von Vögeln
DE102019121526A1 (de) 2019-08-09 2021-02-11 Alzchem Trostberg Gmbh Konzentrat zur Herstellung von Tränklösungen (II)
EP3839051A1 (en) 2019-12-19 2021-06-23 Evonik Operations GmbH Method for the fermentative production of guanidinoacetic acid
CN116133528A (zh) * 2020-06-15 2023-05-16 澳泽化学特罗斯特贝格有限公司 增加动物饲料中的代谢能
JP2023532784A (ja) 2020-07-09 2023-07-31 エボニック オペレーションズ ゲーエムベーハー グアニジノ酢酸の発酵産生方法
BR112023000183A2 (pt) 2020-07-09 2023-01-31 Evonik Operations Gmbh Microrganismo e métodos para produção fermentativa de ácido guanidinoacético e creatina
JP2023539760A (ja) 2020-09-01 2023-09-19 エボニック オペレーションズ ゲーエムベーハー グアニジノ酢酸の製造方法
KR20230057370A (ko) 2020-09-01 2023-04-28 에보닉 오퍼레이션스 게엠베하 구아니디노 아세트산의 제조 방법
KR20240012383A (ko) 2021-05-21 2024-01-29 에보닉 오퍼레이션스 게엠베하 아미노산 엑스포터의 불활성화에 의해 구아니디노 아세트산 (gaa) 제조를 위한 개선된 생명공학 방법
DE102021126581A1 (de) 2021-10-13 2023-04-13 Alzchem Trostberg Gmbh Verwendung eines Futtermitteladditives in energiearmen Futter für Schweine
WO2023196159A1 (en) * 2022-04-08 2023-10-12 Can Technologies, Inc. Fish feed or fish feed additive
WO2023232584A1 (en) 2022-06-03 2023-12-07 Evonik Operations Gmbh Method for producing guanidino acetic acid (gaa)
WO2023232583A1 (en) 2022-06-03 2023-12-07 Evonik Operations Gmbh Improved biotechnological method for producing guanidino acetic acid (gaa) by using nadh-dependent dehydrogenases
CN114751845B (zh) * 2022-06-13 2022-09-20 北京君德同创生物技术股份有限公司 一种易溶的胍基乙酸络合物的合成方法
WO2024094481A1 (en) 2022-11-03 2024-05-10 Evonik Operations Gmbh Improved biotechnological process to produce guanidinoacetic acid (gaa) by targeted introduction or by increasing the activity of a transmembrane exporter protein
WO2024094483A1 (en) 2022-11-03 2024-05-10 Evonik Operations Gmbh Improved biotechnological process to produce guanidinoacetic acid (gaa) by targeted introduction or by increasing the activity of a transmembrane transport protein belonging to the amino acid-polyamine-organocation superfamily

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089771A (en) * 1960-02-16 1963-05-14 Armoar And Company Method of feeding chicks
US5032410A (en) * 1989-05-26 1991-07-16 Kyowa Hakko Kogyo Co., Ltd. Feed composition for culturing fishes
USRE38155E1 (en) * 1996-02-29 2003-06-24 International Flora Technologies Ltd Weight reduction method for dogs and other pets
US20040054006A1 (en) * 1999-06-25 2004-03-18 Rima Kaddurah-Daouk Use of creatine or creatine analogs for the prevention and treatment of Transmissible Spongiform Encephalopathies
US7226947B1 (en) * 1999-05-08 2007-06-05 Alzchem Trostberg Gmbh Use of creatine as a fat substitute

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE738131C (de) 1936-07-26 1943-08-04 Ig Farbenindustrie Ag Eiweissersetzendes Futtermittel
US2654779A (en) 1950-12-23 1953-10-06 Int Minerals & Chem Corp Method of preparation of guanidino fatty acids
US2620354A (en) 1951-01-12 1952-12-02 Int Minerals & Chem Corp Production of guanidino fatty acids
US3843798A (en) * 1973-03-12 1974-10-22 Stanley Drug Products Inc Methods and compositions for inducing resistance to bacterial infections
DE2441777A1 (de) 1974-08-31 1976-03-11 Stanley Drug Products Inc Antibakterielles mittel
DE2937358A1 (de) 1979-09-13 1981-04-02 Erhard Heisler Praeparat aus pflanzlichen und/oder tierischen extrakten zur enteralen und parenteralen ernaehrung
DD206735B1 (de) * 1981-07-15 1985-12-18 Berlin Chemie Veb Verfahren zur anwendung ergotroper wirkstoff-kombinationen in der gefluegelmast
US6413962B1 (en) * 1988-05-02 2002-07-02 N. Eric Naftchi Guanidino compounds effective as anesthetics
IT1237519B (it) 1989-11-27 1993-06-08 Impiego dell'acido guanidinacetico per indurre un incremento del contenuto muscolare di creatina
GB9508443D0 (en) 1995-04-26 1995-06-14 Gilbertson & Page Biscuit for working racing or sporting dogs
BR9711954A (pt) 1996-12-20 1999-08-24 Sueddeutsche Kalkstickstoff Piruvato de creatina e processo para sua prepara-Æo
DE19707694A1 (de) 1997-02-26 1998-08-27 Sueddeutsche Kalkstickstoff Kreatin-ascorbate und Verfahren zu deren Herstellung
DE19836450A1 (de) 1998-08-12 2000-02-17 Sueddeutsche Kalkstickstoff Stabile, Brenztraubensäure (Salze) enthaltende Formulierung für die Tierernährung
GB2358135A (en) * 1999-12-09 2001-07-18 Finnfeeds Int Ltd Animal feed additives comprising betaine and a protease
DE10003835A1 (de) 2000-01-28 2001-08-16 Sueddeutsche Kalkstickstoff Formulierungen bei Dehydratationszuständen
JP3827139B2 (ja) 2000-07-17 2006-09-27 伊藤忠飼料株式会社 グリシンによって強化された採卵鶏用植物性飼料組成物及び採卵鶏の飼育方法
EP1536781B1 (en) 2002-06-19 2010-02-17 N.V. Nutricia Nutritional or pharmaceutical compositions for increasing the creatine response of organisms

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089771A (en) * 1960-02-16 1963-05-14 Armoar And Company Method of feeding chicks
US5032410A (en) * 1989-05-26 1991-07-16 Kyowa Hakko Kogyo Co., Ltd. Feed composition for culturing fishes
USRE38155E1 (en) * 1996-02-29 2003-06-24 International Flora Technologies Ltd Weight reduction method for dogs and other pets
US7226947B1 (en) * 1999-05-08 2007-06-05 Alzchem Trostberg Gmbh Use of creatine as a fat substitute
US20040054006A1 (en) * 1999-06-25 2004-03-18 Rima Kaddurah-Daouk Use of creatine or creatine analogs for the prevention and treatment of Transmissible Spongiform Encephalopathies

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8536222B2 (en) 2005-03-04 2013-09-17 Alzchem Ag Addition compounds of guanidinoacetic acid
US20090297656A1 (en) * 2005-08-02 2009-12-03 Thomas Gastner Liquid Formulation Based On a Guanidinoacetic Acid Component
US20090098239A1 (en) * 2006-03-01 2009-04-16 Alzchem Trostberg Gmbh Ready-to-Eat Feed for Domestic Pets
US20100143703A1 (en) * 2007-07-21 2010-06-10 Stephan Winkler Abrasion-resistant free-flowing glycocyamine-containing mouldings and methods for their production
US11633373B2 (en) 2020-03-04 2023-04-25 Alzchem Trostberg Gmbh Method for reduction of behavioral disorders in pigs
CN114938830A (zh) * 2022-05-05 2022-08-26 北京中科万联科技有限公司 一种基于氨基酸提升畜禽瘦肉率的饲料添加剂及其制备方法和应用
CN115553403A (zh) * 2022-11-03 2023-01-03 上海海洋大学 凡纳滨对虾肉质改善剂及其制备方法和应用

Also Published As

Publication number Publication date
KR101230977B1 (ko) 2013-02-07
WO2005120246A1 (de) 2005-12-22
ZA200609861B (en) 2007-12-27
PT1758463E (pt) 2008-04-03
KR20070034052A (ko) 2007-03-27
JP5227021B2 (ja) 2013-07-03
CA2569269A1 (en) 2005-12-22
AU2005251451A1 (en) 2005-12-22
DE502005002355D1 (de) 2008-02-07
US20130296431A1 (en) 2013-11-07
HRP20080035T3 (en) 2008-07-31
RU2006146983A (ru) 2008-07-20
BRPI0511842B1 (pt) 2014-08-12
NZ551661A (en) 2009-10-30
AU2005251451B2 (en) 2010-12-02
CY1107249T1 (el) 2012-11-21
CA2569269C (en) 2011-12-20
JP2008501352A (ja) 2008-01-24
RS50556B (sr) 2010-05-07
DK1758463T3 (da) 2008-05-05
ATE381892T1 (de) 2008-01-15
NO335082B1 (no) 2014-09-08
US8501810B2 (en) 2013-08-06
EP1758463B1 (de) 2007-12-26
MXPA06014279A (es) 2007-07-25
CN1964633B (zh) 2011-04-27
NO20066085L (no) 2006-12-29
RU2341972C2 (ru) 2008-12-27
BRPI0511842A (pt) 2008-01-15
EP1758463A1 (de) 2007-03-07
US20110257075A1 (en) 2011-10-20
CN1964633A (zh) 2007-05-16
HK1096263A1 (en) 2007-06-01
ES2296186T3 (es) 2008-04-16
SI1758463T1 (sl) 2008-08-31
PL1758463T3 (pl) 2008-04-30

Similar Documents

Publication Publication Date Title
US8501810B2 (en) Guanidino acetic acid used as an animal food additive
AU2007220681B2 (en) Ready-to-eat feed for domestic pets
JP5284088B2 (ja) グアニジノ酢酸成分をベースとする液体配合物
RU2402921C2 (ru) Соли, продукты присоединения и комплексные соединения гуанидинуксусной кислоты
US8703819B2 (en) Use of guanidinoacetic acid (salts) combination with betaine and/or choline to produced an agent that is beneficial to health
DK202370244A1 (en) Use of guanidinoacetic acid and/or creatine in aquaculture
BR112016017464B1 (pt) Uso de ácido guanidinoacético e/ou creatina e sais destes e método para aumentar a taxa de eclosão de ovos
JP2010508249A (ja) クレアチン成分を含有する固形の又は水性のアルカリ性調製物、その製造方法及びその使用

Legal Events

Date Code Title Description
AS Assignment

Owner name: DEGUSSA AG, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:GASTNER, THOMAS;KRIMMER, HANS-PETER;REEL/FRAME:018677/0538

Effective date: 20061027

AS Assignment

Owner name: ALZCHEM TROSTBERG GMBH, GERMANY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:DEGUSSA AG;REEL/FRAME:020288/0418

Effective date: 20061218

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION